Stockholders' Deficiency (Details Narrative) (USD $)			6 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended
	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014 Stock Warrants [Member]	Jun. 30, 2013 Stock Warrants [Member]	Jun. 30, 2014 Stock Option [Member]	Jun. 30, 2013 Stock Option [Member]	Jun. 30, 2014 Stock Option [Member]	Jun. 30, 2013 Stock Option [Member]	Jun. 30, 2014 Stock Warrants [Member]	Jun. 30, 2013 Stock Warrants [Member]
Weighted average fair value			$ 0.21						$ 0.17
Selling, General And Administrative Expenses			$ (588)	$ 514,364	$ 106,352	$ 13,799	$ 268,851	$ 326,243	$ (852)	$ 9,587
Stock-Based Compensation Expense related to stock options, unamortized					1,325,510		1,325,510		578,831
Stock-Based Compensation Expense, Unamortized					433,941		433,941		1,991
Weighted Average Remaining Period				1 year 3 months 18 days			1 year 4 months 24 days
Performance based option vesting					891,569		891,569		576,840
Dividend related to the Series B convertible preferred stock.	$ 149,459	$ 279,380